Keywords: ucb, pharma, debuts, keppra, france, following, finalization

UCB Pharma debuts Keppra in France

Article | 29 September 2003

Following finalization of reimbursement, Belgium's UCB Pharma has launched its Keppra (levetiracetam), for the adjunctive treatment of partial seizures in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

UCB

Go to company listing

Related Drugs

Keppra

Levetiracetam

Keppra Injection

Go to drug listing